b.fab is a German-based startup with a mission to bring C1 Bioeconomy into practice. Specializing in the efficient conversion of CO2 and hydrogen (H2) from renewable energy into biotechnological value chains, b.fab leverages formate as a central mediator to bind and store CO2 and H2 in liquid form. Using synthetic biology, they design specific pathways to convert formate into value-added chemicals. With a platform built on anaerobic and aerobic microbial production hosts, b.fab offers flexibility in process design and adaptation to specific product requirements.
Founded in 2018, b.fab is dedicated to establishing a Formate Bioeconomy, providing an economical and sustainable new way to produce value-added chemicals for various industries. In January 2021, the company secured a Venture Round investment led by b.value AG.
The company's focus on biotechnology and sustainability, alongside its innovative approach to utilizing CO2 and H2, positions b.fab as a promising player in the emerging bioeconomy market. With a strong emphasis on efficient bioprocess development and a commitment to sustainability, the startup presents an attractive opportunity for investors seeking exposure to the growing biotech and sustainable industries.